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Kemel Arafet, Katarzyna Świderek, and Vicent Moliner*
Departament de Química Física i Analítica, Universitat Jaume I, 12071 Castello,́ Spain
*S Supporting Information
ABSTRACT: Cruzain, a cysteine protease of the papain family, is essential in
the development of the protozoan Trypanosoma cruzi, the etiologic agent of
Chagas disease, making it an attractive target for developing new drugs. The
present paper is aimed at the study of the catalytic mechanism of the cruzain
by ﬁrst exploring the diﬀerent protonation states of the active site Cys25 and
His159 in the Michaelis complex and the eﬀect on the full catalytic
mechanism of this enzyme. The exploration of the equilibrium between these
two states has been performed with alchemical free energy perturbation
methods with molecular mechanics (MM) force ﬁelds and by generating the
free energy surfaces in terms of the potential of mean force computed at two
levels of theory: AM1d/MM and M06-2X/6-31+G(d,p):AM1d/MM.
Alternative mechanisms for the acylation step have been identiﬁed on the
free energy surfaces and the results suggest the existence of three new reaction
mechanisms starting from the peptide binding to the apoenzyme in its neutral Cys25S/His159 dyad state. The mechanism
starting with the protonation of the nitrogen atom of the peptide followed by the attack of Cys25S− was revealed as the most
favorable one, but it can be competitive with its counterpart mechanism initiated in the Cys25S−/His159H+ ion pair Michaelis
complex. Analysis of energetic and average geometries will allow continuing improvement of our knowledge on this enzyme at
the molecular level, which can be crucial to the design of new inhibitors based on the structures of the transition states
(transition states analogues) or stable intermediates.
■ INTRODUCTION
Cysteine proteases of the papain family are essential enzymes
to the life cycle of several parasitic protozoa, making them
attractive targets for developing new drugs.1 For instance,
rhodesian is expressed by the protozoa Trypanosoma brucei
rhodesiense, which is responsible for the African sleeping
sickness;2 falcipain-2 is a drug target against Malaria.3 Cruzain
cysteine protease is expressed by Trypanosoma cruzi, the
etiologic agent of Chagas disease,1 which concerns 8 millions
of people living mainly in endemic Latin American countries.4
This important class of enzymes are involved in the hydrolysis
of peptides and proteins (see Scheme 1) which explains why
they are commonly implicated in severe human disease
progression.5 The high catalytic activity of cysteine proteases
has been related to the nucleophilic character of their active
site, enhanced by the formation of CysS−/HisH+ ion pair.6
Nevertheless, a debate is open about the timing of the
formation of this reactive complex.
Polgar, in the spectrophotometric determination of pH-
dependence of the reaction catalyzed by the cysteine protease
papain, concluded that the ion pair formation is responsible for
the high reactivity of the cysteine proteases.7,8 Shafer and co-
workers, in diﬀerent experimental studies on papain, show that
the tautomeric relationship between neutral and ionic dyads is
such that the thiolate:imidazolium dyad is favored.9,10 Later
Polgar and co-workers, in a kinetic study with the picornain 3C
cysteine protease, proposed that this enzyme does not have a
catalytic ion pair.11 In 2008, Engels and co-workers showed
that the ion pair was about 7.2 kcal mol−1 lower in energy than
the neutral form based on molecular dynamics (MD)
simulations on cathepsin B, a cysteine protease of the papain
family.12 Moreover, according to their calculations, the enzyme
environment would stabilize the ion pair by more than 23.8
kcal mol−1 related to the gas phase, and by more than 9.6 kcal
mol−1 compared with the ion pair in aqueous solution.
However, Albeck and co-workers using the quantum
mechanical (QM) methods and a continuum model to
mimic the environment, studied the protonation state of the
Cys25−His59 (papain numbering) catalytic dyad in free
papain and concluded that both residues are protonated at
neutral pH.13 It is nevertheless diﬃcult to envision how the
fully protonated form could manage catalysis. Later, the same
authors in a study of the inhibition mechanism of papain by
peptidyl aldehydes suggested that the ion pair is not important
for the catalytic mechanism of the papain family of cysteine
proteases.14 Grazioso and co-workers, based on the generation
of potential energy surfaces (PES) of the mechanism for
falcipain-2 inhibition by α,β-unsaturated benzo[1,4]diazepin-2-
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one methyl ester using hybrid QM/molecular mechanics
(MM) methods, proposed that the activation of Cys42 by
His174 (falcipain-2 numbering) is not the rate-limiting step
and occur without important change in the relative energy of
the system.15 Zhan and co-workers16 studied the hydrolysis of
N-acetyl-Phe-Gly-4-nitroanilide catalyzed by papain based on
pseudobond ﬁrst-principles with QM/MM potentials, showing
that the ion pair is slightly more stable than the neutral form.
More recently, based on the kinetic studies of cruzain, Zhai
and Meek proposed that both catalytic cysteine and histidine
residues are neutral in the free enzyme and the formation of
the ion pair only takes place upon substrate binding.17
A QM/MM study of the catalytic mechanism of the cruzain
cysteine protease, based on MD simulations using semi-
empirical AM1d Hamiltonian and the M06-2X functional to
describe the QM sub-set of atoms, was recently carried out in
our laboratory.18 In this case, it was assumed that a substrate
was bound to the Cys25S−/His59H+ ion pair (RSe‑p
+/−) as a
starting point (see mechanisms I, II, and III in Scheme 2). Our
results indicated that the acylation stage takes place in two
steps; ﬁrst, the proton from a histidine residue (His159) is
transferred to the N1 atom of the peptide, which is followed by
Cys25 attack to the carbonyl carbon atom (mechanism II in
Scheme 2). After acylation, deacylation takes place through a
Scheme 1. Peptide Hydrolysis Catalyzed by Cysteine Proteases
Scheme 2. Proposed Full Reaction Mechanisms of the Cruzaina
aThe mechanisms I, II, and III are reported in ref 18.
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concerted mechanism being the rate-limiting step of the full
catalytic process.
We herein continue with the study of the catalytic
mechanism of the cruzain by exploring the importance of
active site protonation states, which is indeed a crucial aspect
of enzymology. Our simulations will try to answer the key
question of whether the reaction begins with the thiol being
thiolate or not. In other words, the equilibrium between the
two possible Michaelis complexes, the neutral Cys25/His59
dyad, RSe‑p
0/0, and the RSe‑p
+/− ion pair, was explored. Then, the
ﬁrst stage of the full catalytic mechanism of this enzyme, the
acylation step, was explored from the former. As observed in
Scheme 2, the acylation step is herein proposed to take place
through three new possible mechanisms starting from the
neutral RSe‑p
0/0 state, mechanisms IV, V, and VI. Mechanism IV
implies the direct formation of an intermediate where the
neutral Cys25SH transfers the proton to the nitrogen atom of
the scissile peptide bond of the substrate (intermediate IV,
equivalent to intermediate II). The acylation step through the
formation of a protonated thiohemiketal intermediate, THH, is
explored in mechanism V, after a preliminary protonation of
the carbonyl group of the peptide. The last explored
mechanism, mechanism VI, involves the formation of a
transient thiohemiketal (THA) intermediate. Free energy
surfaces (FESs) corresponding to every possible chemical
step will be generated and analyzed. Moreover, in this paper we
Figure 1. (a) Schematic representation of the equilibrium between the neutral and ion pair dyad in the absence of the peptide in the active site; and
(b) the corresponding one-dimensional potential of mean force (1D-PMFs) computed at the M06-2X/6-31+G(d,p):AM1d/MM level.
Figure 2. (a) 1D-PMFs for the proton transfer from Cys25 to His159 computed at the M06-2X/6-31+G(d,p):AM1d/MM level in the peptide−
enzyme complex model. (b) Snapshots of representative structures of the ion pair and the neutral dyad. Peptide is represented as a ribbon.
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are also exploring the relative stability of the ion pair and the
neutral forms of the protein−peptide complex which can be
crucial to determine the most favourable reaction path. The
analysis of energetics and average geometries along the
reaction progress allow extracting the conclusions, that closes
the present paper.
■ RESULTS AND DISCUSSION
We started our study by exploring the equilibrium between the
neutral and ion pair dyad in the absence of the peptide in the
active site (see Figure 1a).
As explained in the previous section, the FES for this step
was computed as a 1D-PMF using the antisymmetric
combination of the distances deﬁning the proton transfer
from Cys25 to His159, but also by classical alchemical free
energy perturbation (FEP) methods. Figure 1b shows the
energy proﬁle corrected at the M06-2X/6-31+G(d,p):AM1d/
MM level (the 1D-PMF at the AM1d/MM level is presented
in Figure S3 in the Supporting Information). As noticed, the
ion pair form of the free enzyme, RSe
+/−, is more stable than the
neutral form, RSe
0/0, with a very low barrier for the formation of
the Cys25/His159 ion pair (ca. 2 kcal mol−1). This result is in
qualitatively good agreement with classical alchemical calcu-
lations that predicts RSe
+/− to be 9.5 kcal mol−1, more stable
than RSe
0/0. It must be kept in mind that the PMF is computed
with QM/MM methods, whereas the full system is treated by
MM in the alchemical FEP calculations. In any case, both
methods suggest that the peptide would bond to the most
populated state of the free protein, i.e., the cavity where the ion
pair is already formed. The acylation step would then start
from this state, RSe‑p
+/−, as assumed in our previous study of the
cruzain catalyzed reaction.15 Representative snapshots of the
ion pair and the dyad is presented in Figure S4 in the
Supporting Information.
Nevertheless, the exploration of the free energy surface
corresponding to the transfer of the proton from Cys25 to
His159, shown in Figure 2a, indicates that when the peptide
binds the protein, the stability of Michaelis complex is slightly
shifted in favor of RSe‑p
0/0, and thus this step has to be taken into
consideration in the exploration of the full reaction
mechanism. Analysis of the average structures of the two
states (see Figure 2b) reveals that the donor and acceptor
inter-atomic distance, SG(C25) and N2(H159), are 3.17 ±
0.15 and 3.97 ± 0.21 Å, in the RSe
0/0 and RSe‑p
0/0, respectively
(see Table S1 in the Supporting Information for the list of key
inter-atomic distances), which means that no large displace-
ments are required in the active site for the transfer of the
proton between these two residues in either of the free enzyme
or the enzyme−peptide complex. Of note, the free energy
barrier from RSe‑p
+/− to RSe‑p
0/0, 13.4 kcal mol−1, is very close to
the value deduced from the rate constants measured by Zhai
and Meek that oscillate between 14.0 and 14.8 kcal mol−1,
depending on the peptide used in the experiments.17
Acylation Stage through Mechanism IV. The next step
of our study was the exploration of the acylation stage from the
conformation of the active site with Cys25 and His159 as
neutral species, RSe‑p
0/0. The results are compared with the
results obtained in our previous study,18 where the starting
state of the acylation step catalyzed by cruzain was assumed to
be the ion pair (see Scheme 2). The FES for this step, shown
in Figure 3 as a two-dimensional PMF (2D-PMF) (see the
corresponding 2D-PMF AM1d/MM in Figure S5 of the
Supporting Information), describes the acylation stage as a
stepwise mechanism through an intermediate I−IV. As
deduced from the FES and reﬂected in the structures displayed
in Figure 4 (a list of key inter-atomic distances of the involved
states are reported in Table S2 in the Supporting Information),
the proton of Cys25 is transferred directly to the N1 atom of
the peptide (1.01 ± 0.02 Å in I−IV), but the bond between
thiolate and the C1 atom of the peptide is not formed (SG−C1
distance equal to 3.60 ± 0.03 Å). From this intermediate, the
acylation step is completed by the formation of the covalent
bond between the sulfur atom of Cys25 and the C1 atom of
the peptide (1.73 ± 0.02 Å), concomitant with the breaking of
its N1−C1 bond (3.38 ± 0.19 Å).
Figure 5 displays the free energy proﬁle obtained for the
acylation step catalyzed by cruzain through mechanism IV and
compared with the most favorable reaction path obtained
previously in our laboratory through mechanism II starting
from the ion pair reactant complex, RSe‑p
+/−.18 Interestingly,
when adding the relative energy between RSe‑p
0/0 and RSe‑p
+/−,
presented in Figure 2a, to the acylation step obtained through
mechanism IV, it appears that the two mechanisms can be
considered as competitive. The highest energy transition state
(TS) of mechanism IV (21.3 kcal mol−1) is just 2.1 kcal mol−1
lower than the highest energy TS of mechanism II (23.4 kcal
mol−1) but, due to the stabilization of RSe‑p
0/0, the later presents
a step with the highest energy barrier (23.7 kcal mol−1).
Superposition of representative snapshots of the intermediates
I and IA obtained from the exploration of mechanisms II and
IV are presented in Figure S6 in the Supporting Information.
Acylation Stage through Mechanism V. The explora-
tion of mechanism V from the RSe‑p
0/0 reactant complex has been
based on the generation of the FES presented in Figure 6. The
2D-PMF at the AM1d/MM level is deposited in the
Supporting Information as Figure S7. As observed in the
ﬁgure, a protonated thiohemiketal intermediate, THH-V, is
Figure 3. M06-2X/6-31+G(d,p):AM1d/MM FES for the acylation
step through mechanism IV. Iso-energetic lines are displayed every 1.5
kcal mol−1.
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formed in a stepwise manner through an intermediate, I−V.
This stable intermediate is characterized by a deprotonated
Cys25 and a protonated carbonyl oxygen O1 atom of the
peptide (see Scheme 2, Figure 7 and the list of inter-atomic
distances reported in Table S3 of the Supporting Information).
From this structure, the active thiolate attacks the C1 atom of
the peptide, thus producing the THH-V intermediate. A stable
intermediate before the formation of THH-V was already
detected in our previous study when the acylation step of the
cruzain reaction was considered to start from the ion pair
RSe‑p
+/−.18 The comparison of the average structures conﬁrms
that both intermediates, I−V and I−III, correspond to the
same state (see representative snapshots presented in Figure
S8 in the Supporting Information). The evolution from THH-
Figure 4. Representative snapshots of the key states located along mechanism IV. Distances are given in Å.
Figure 5. Free energy proﬁle corresponding to the acylation stage
through mechanism II obtained in ref 18 (black line) and mechanism
IV (blue line). Both proﬁles derived from FESs computed at the M06-
2X/6-31+G(d,p):AM1d/MM level.
Figure 6. M06-2X/6-31+G(d,p):AM1d/MM FES for the formation
of the THH-V intermediate. Iso-energetic lines are displayed every 1.5
kcal mol−1.
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V to the ﬁnal intermediate of the acylation step, IA, rendered a
free energy barrier of 32.7 kcal mol−1,18 thus precluding the
feasibility of this mechanism.
The resulting free energy proﬁles from RSe‑p
+/− to the
formation of the THH intermediate through mechanisms III
and V, depicted in Figure 8, indicate that the new mechanism
V could be competitive with mechanism III. Nevertheless,
taking into account the high energy barrier required for the
transformation between THH and the ﬁnal product of the
acylation step of the full reaction catalyzed by cruzain (32.7
kcal mol−1, as reported in our previous study18), the present
results conﬁrm the reaction mechanism through a THH
intermediate as unfeasible.
Acylation Stage through Mechanism VI. Finally, an
acylation mechanism through a thiohemiketal intermediate,
denoted as THA, was explored from the RSe‑p
0/0 reactant
complex. This mechanism was explored in our previous study
from the ion pair RSe‑p
+/− but the FES showed that the formation
of THA required a signiﬁcantly high energy (ca. 48 kcal mol−1
higher in energy than the reactant state).18 The instability of
this kind of thiohemiketal tetrahedral intermediate was already
observed in our previous study of the inhibition of cruzain.19 In
the present study, the FES, generated with the SG−C1
distance and the antisymmetric combination of distances
deﬁned for the hydrogen transfer between Cys25 and His159,
d(SG−H2)−d(N2−H2) as reaction coordinates (see Figure
S9 in the Supporting Information), corroborates that a THA
intermediate does not represent a feasible stable intermediate
(the free energy diﬀerence between THA and RSe‑p
0/0 was 54.1
kcal mol−1 at the M06-2X/6-31+G(d,p):AM1d/MM level).
Accordingly, this mechanism was discarded as a competitive
reaction path for the acylation step.
■ CONCLUSIONS
Free energy surfaces for the acylation step in cruzain have been
obtained in terms of 1D- and 2D-PMFs with hybrid QM/MM
potentials. The results, together with the estimation of the
relative energy between the two possible conformations of the
enzyme active site, the Cys25S−/His159H+ ion pair dyad, and
the neutral Cys25SH/His159 form, obtained from alchemical
Figure 7. Representative snapshots of the key states located along mechanism V. Distances are given in Å.
Figure 8. Free energy proﬁle corresponding to the formation of IA
intermediate through mechanism III obtained from ref 18 (black line)
and mechanism V (red line). Both proﬁles derived from FESs
computed at the M06-2X/6-31+G(d,p):AM1d/MM level.
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FEP methods, have allowed obtaining a picture of the full
catalytic process.
The QM/MM free energy surface associated with the
transfer of the proton from Cys25H to His159 in the absence
of peptide in the cavity of the enzyme, in agreement with the
classical FEP calculations, reveals that the equilibrium is
displaced towards the more stable ion pair dyad, Cys25−/
His159H+, RSe‑p
+/−. Nevertheless, when the peptide is bound in
the active site the diﬀerences in energy between the two
possible Michaelis complex conformations are reduced, slightly
shifted to the stabilization of the neutral Cys25SH/His159
form, RSe‑p
0/0, by ca. 4 kcal mol−1. The activation-free energy
from RSe‑p
+/− to RSe‑p
0/0 is close to the value deduced from the rate
constants reported by Zhai and Meek.17 Consequently, RSe‑p
0/0
must be considered as a possible Michaelis complex in the
evaluation of the possible mechanisms of the acylation stage
catalyzed by cruzain. In the present paper we are presenting
three mechanisms not explored in our previous study, where
the ion pair dyad was considered as the starting point of the
acylation stage,18 by considering the neutral form, RSe‑p
0/0, as the
starting point.
The complete free energy landscape suggests that the most
favorable reaction path for the acylation step initiated from the
neutral Michaelis complex proceeds through a direct proton
transfer from Cys25 to the nitrogen atom of the scissile bond
of the peptide (see mechanism IV in Scheme 2). Then, the
sulfur atom of the activated thiolate would attack the carbon
atom of the peptide, thus provoking the C−N breaking bond.
Interestingly, when taking into account the relative energy
between the two reactant complexes, the acylation step
obtained through this mechanism IV appears to be competitive
with the previously explored mechanism II (see Scheme 2).
The highest energy TS of mechanism IV is just 2.1 kcal mol−1
lower than the highest energy TS of mechanism II but, due to
the stabilization of the protein−peptide reactant complex when
Cys25 and His159 residues are neutral, the later presents a step
with the highest energy barrier. Alternative mechanisms
involving the formation of a protonated or unprotonated
tetrahedral thiohemiketal intermediates have been explored but
they must be discarded according to the associated high energy
barriers.
In all, the present results suggest that the reaction can also
take place through the formation of a protein−peptide
complex with the catalytic cysteine and histidine in their
neutral forms. The fact that the newly explored mechanism
shows activation-free energy barriers similar to previously
published ones that started from the ion pair Michaelis
complex opens new frontiers to future developments in
designing new drugs (mimicking for instance new identiﬁed
TSs) for Chagas disease.
■ COMPUTATIONAL METHODS
Our ﬁrst molecular model corresponding to the peptide−
protein complex consists of one chain of 215 amino acids
(cruzain) and the peptide Ac−Ala−Ala−Ala−Gly−Ala−
OCH3. This model was constructed from the X-ray crystal
structure of cruzain from T. cruzi with PDB code 1AIM20 and
2.0 Å resolution, that contains Bz−Tyr−Ala−CH2F in the
active site. The covalent inhibitor Bz−Tyr−Ala−CH2F was
replaced by the peptide Ac−Ala−Ala−Ala−Gly−Ala−OCH3.
Taking into account the low substrate speciﬁcity of this
protein,21−23 this peptide was chosen because it was already
used in our previous study of the catalytic mechanism from the
ion pair dyad, thus facilitating the comparison between
mechanisms.18 In addition, it presents computational advan-
tages due to its small size. The selected bond cleavage was the
Ala3−Gly4 peptide bond (see Figure 9a). The cruzain cysteine
protease speciﬁcity for the residue−residue peptide bond has
been recently investigated by Zhai and Meek.17 Their
experimental kinetic studies suggest that a larger charge
residue at the P1 position is preferred for catalysis, whereas a
hydrophobic residue is more favorable than a charged one at
the P2 position. The missing hydrogen atoms of the X-ray
structure were introduced at pH 7 using the fDYNAMO
library,24 within the pKa values of the titratable residues
calculated within the empirical PROPKA 3.1 program.25 The
protonation state of His159 and Cys25 was studied in detail by
exploring the free energy surfaces, as detailed below. Eleven
counterions (Na+) were placed into optimal electrostatic
positions (those where the potential reaches maximum
negative values) around the enzyme (further than 10.5 Å
from any atom of the system and 5 Å from any other
counterion, using a regular grid of 0.5 Å), to obtain the
electroneutrality of the system. Once the system was complete,
it was solvated by a 79.5 Å side cubic box of water molecules.
The QM region, ﬁrst described with the AM1d semi-
empirical Hamiltonian,26 contains the full peptide, residue
Cys25, the imidazole ring of His159, the side chain of Gln19,
and one water molecule (88 atoms, see Figure 9a). This is the
Hamiltonian already employed in the exploration of mecha-
Figure 9. Details of the atoms of the active site treated quantum mechanically (blue regions) in (a) the peptide−protein complex, where R1
correspond to CH3CO−(Ala)2 and R2 correspond to Ala−CH3, and (b) the free protein. Black dots represent the hydrogen link atoms.
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nisms I, II, and III reported in our previous study.18 Recently,
Lameira and co-workers27 in a study combining experiments
and computational modeling, employed the same Hamiltonian
to compute the free energy surface of the inhibition of cruzain
cysteine protease by dipeptidyl nitriles, with results in
accordance with the available experimental data. The rest of
the system, protein and water molecules, was described by the
OPLS-AA28 and TIP3P29 force ﬁelds, respectively. Hydrogen
link atoms were used to saturate the valence of the QM−MM
frontier bonds.30 All residues further than 25 Å from the C1
atom of the peptide were kept frozen during the simulations
(43 115 atoms from a total of 50 029). A force switching
function with a cut-oﬀ distance in the range of 14.5−16 Å and
periodic boundary conditions were employed and used to treat
the nonbonding interactions. The fDYNAMO library24 was
used for the QM/MM calculations. The reactants, products,
intermediates, and transition state structures were optimized
by means of a micro−macro iteration scheme.31
Once the PESs of every chemical step were explored, free
energy surfaces (FESs), in terms of the potential of mean force
(PMF), were generated using umbrella sampling and the
weighted histogram analysis method to recover the proba-
bilities.32,33 The error associated with this method, when
properly carried out, is usually accepted to be around 1 kcal
mol−1.34 The harmonic umbrella sampling force constants was
2500 kJ mol−1 Å−2. A plot showing the proper overlapping of
the sampling in consecutive windows is deposited in the
Supporting Information (Figure S1). 20 ps of equilibration and
40 ps of production, with a time step of 1 fs, were used in every
window of the PMFs. To obtain averaged geometrical
parameters, 200 ps of AM1d/MM MD simulations of the
windows corresponding to the diﬀerent states were performed.
Because no X-ray structure has been solved for the free
protein, a second molecular model was prepared in which the
peptide was removed from the active site of the ﬁrst model.
Twenty nanoseconds of classical MD simulation were required
to equilibrate the new system employing NAMD parallel
molecular dynamics code.35 The structure of the apoenzyme
was conﬁrmed to be equilibrated by the analysis of the time
evolution of the root-mean-square-deviation (RMSD) (see
Figure S2). The MD simulations were carried out at 300 K
using NVT ensemble and the Langevin−Verlet integrator
using a time step of 1 fs. The protein atoms were treated with
the CHARMM36 force ﬁeld and the water molecules were
treated with the TIP3P37 force ﬁelds; both as implemented in
NAMD.35 For further QM/MM calculations in this new
model, fDYNAMO library24 was employed with the QM
region containing just the residue Cys25 and the imidazole
ring of His159 (19 atoms, as depicted in Figure 9b). The
equilibrium between the neutral and the ion pair dyad for the
free enzyme (model 2, Figure 9b) was explored by generating a
monodimensional AM1d/MM PMFs (1D-PMF) with the
antisymmetric combination of the bond-forming and bond-
breaking distances, d(SG−H2)−d(N2−H2) as the reaction
coordinate. In addition, calculations based on classical
alchemical free energy perturbation methods (FEP) were
also carried out to study this transformation of the active site
without the peptide. NAMD was employed for carrying out
these calculations (see the Supporting Information for details).
Model 1 (Figure 9a) was employed to study the equilibrium
between the neutral and the ion pair dyad in the peptide−
protein complex, as well as for the exploration of the acylation
step, by generating the free energy surfaces of every single
chemical step. Similar to the study in the apoenzyme, a
monodimensional AM1d/MM PMFs (1D-PMF) was gener-
ated with the antisymmetric combination of the bond-forming
and bond-breaking distances, d(SG−H2)−d(N2−H2) as the
reaction coordinate. In the case of mechanism IV (starting
from the RSe‑p
0/0 complex as depicted in Scheme 2), a two-
dimensional PMF (2D-PMF) was computed at the AM1d/
MM level using as ζ1 the bond-forming distance between Cys
and carbon of scissile peptide bond, d(SG−C1), and as ζ2 the
antisymmetric combination of distances deﬁned for the
hydrogen transfer between Cys25 and nitrogen of the same
peptide bond, d(SG−H2)−d(N1−H2). A total of 2187
simulation windows were used to generate this free energy
surface. For the exploration of mechanism V (starting from the
RSe‑p
0/0 complex as depicted in Scheme 2), a 2D-PMF was
computed where the SG−C1 distance was deﬁned as ζ1, and
the antisymmetric combination of two distances deﬁned for
the hydrogen transfer, ζ2 but this time from Cys25 to oxygen
of the carbonyl group, d(SG−H2)−d(O1−H2). A total of
2989 simulation windows were required to generate this 2D-
PMF. Finally, for the exploration of mechanism VI (starting
from the RSe‑p
0/0 complex as depicted in Scheme 2), a 2D-PMF
was computed where the SG−C1 distance was deﬁned as ζ1,
and as ζ2 the antisymmetric combination of distances deﬁned
for the hydrogen transfer between Cys25 and His159, d(SG−
H2)−d(N2−H2). This required a series of 1519 simulation
windows.
The QM sub-set of atoms in the QM/MM FESs were
restricted to low-level because of the computer limitations. To
improve the level of theory, an interpolated correction scheme
with a higher level Hamiltonian, developed in our laboratory,38
was applied as explained in detail in our previous paper.18 The
M06-2X functional39 with the standard 6-31+G(d,p) basis
set,40 following Truhlar and co-workers suggestions,39,41 was
used employing the Gaussian 09 program,42 combined with
the fDYNAMO library.24
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(7) Polgaŕ, L. Mode of activation of catalytically essential sulfhydryl
group of papain. Eur. J. Biochem. 1973, 33, 104−109.
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